Thomas F. Tropea

Neurofilament Light Chain as a Biomarker for Cognitive Decline in Parkinson Disease

Whitley W. Aamodt, Teresa Waligórska, Junchao Shen et al. · Movement Disorders · 2021 · 177 citations · Full text

Life Sciences, Neurology, Neuroscience +17

GPNMB confers risk for Parkinson’s disease through interaction with α-synuclein

Maria E. Diaz‐Ortiz, Yunji Seo, Marijan Posavi et al. · Science · 2022 · 152 citations · Full text

Life Sciences, Genetics, Neuroscience +17

Enhanced CREB and DARPP‐32 phosphorylation in the nucleus accumbens and CREB, ERK, and GluR1 phosphorylation in the dorsal hippocampus is associated with cocaine‐conditioned place preference behavior

Thomas F. Tropea, Barry E. Kosofsky, Anjali M. Rajadhyaksha · Journal of Neurochemistry · 2008 · 90 citations · Full text

Medicine, Neurobiology, Neuroscience +17

Parkinson’s disease variant detection and disclosure: PD GENEration, a North American study

Lola Cook, Jennifer Verbrugge, Tae‐Hwi Schwantes‐An et al. · Brain · 2024 · 89 citations · Full text

Life Sciences, Genetics, Neurology +16

<i>TMEM106B</i> Effect on cognition in Parkinson disease and frontotemporal dementia

Thomas F. Tropea, Jordan Mak, Michael H. Guo et al. · Annals of Neurology · 2019 · 87 citations · Full text

Medicine, Genetics, Neurology +17